Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Computational Immunology market report explains the definition, types, applications, major countries, and major players of the Computational Immunology market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
IMGT
Dassault Systemes
Strand Life Sciences
Nimbus Discovery
Certara
Novozymes Biopharma
Simulation Plus
Leadscope Inc
ioGenetics
International Society of Vaccines
Schrodinger
Compugen
Genedata AG
Chemical Computing Group
EpiVax
Insilico Biotechnology AG
Rosa & Co
By Type:
Cancer Diagnosis & Therapy
Reverse Vaccinology
Immune System Modeling
By End-User:
Allergy Prediction Databases
Analysis Resource Database
International Immunogenetics System
The Ontology Of Immune Epitopes
Immune Epitope Database
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Computational Immunology Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Computational Immunology Outlook to 2028- Original Forecasts
-
2.2 Computational Immunology Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Computational Immunology Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Computational Immunology Market- Recent Developments
-
6.1 Computational Immunology Market News and Developments
-
6.2 Computational Immunology Market Deals Landscape
7 Computational Immunology Raw Materials and Cost Structure Analysis
-
7.1 Computational Immunology Key Raw Materials
-
7.2 Computational Immunology Price Trend of Key Raw Materials
-
7.3 Computational Immunology Key Suppliers of Raw Materials
-
7.4 Computational Immunology Market Concentration Rate of Raw Materials
-
7.5 Computational Immunology Cost Structure Analysis
-
7.5.1 Computational Immunology Raw Materials Analysis
-
7.5.2 Computational Immunology Labor Cost Analysis
-
7.5.3 Computational Immunology Manufacturing Expenses Analysis
8 Global Computational Immunology Import and Export Analysis (Top 10 Countries)
-
8.1 Global Computational Immunology Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Computational Immunology Export by Region (Top 10 Countries) (2017-2028)
9 Global Computational Immunology Market Outlook by Types and Applications to 2022
-
9.1 Global Computational Immunology Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Cancer Diagnosis & Therapy Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Reverse Vaccinology Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Immune System Modeling Consumption and Growth Rate (2017-2022)
-
9.2 Global Computational Immunology Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Allergy Prediction Databases Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Analysis Resource Database Consumption and Growth Rate (2017-2022)
-
9.2.3 Global International Immunogenetics System Consumption and Growth Rate (2017-2022)
-
9.2.4 Global The Ontology Of Immune Epitopes Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Immune Epitope Database Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Computational Immunology Market Analysis and Outlook till 2022
-
10.1 Global Computational Immunology Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Computational Immunology Consumption (2017-2022)
-
10.2.2 Canada Computational Immunology Consumption (2017-2022)
-
10.2.3 Mexico Computational Immunology Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Computational Immunology Consumption (2017-2022)
-
10.3.2 UK Computational Immunology Consumption (2017-2022)
-
10.3.3 Spain Computational Immunology Consumption (2017-2022)
-
10.3.4 Belgium Computational Immunology Consumption (2017-2022)
-
10.3.5 France Computational Immunology Consumption (2017-2022)
-
10.3.6 Italy Computational Immunology Consumption (2017-2022)
-
10.3.7 Denmark Computational Immunology Consumption (2017-2022)
-
10.3.8 Finland Computational Immunology Consumption (2017-2022)
-
10.3.9 Norway Computational Immunology Consumption (2017-2022)
-
10.3.10 Sweden Computational Immunology Consumption (2017-2022)
-
10.3.11 Poland Computational Immunology Consumption (2017-2022)
-
10.3.12 Russia Computational Immunology Consumption (2017-2022)
-
10.3.13 Turkey Computational Immunology Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Computational Immunology Consumption (2017-2022)
-
10.4.2 Japan Computational Immunology Consumption (2017-2022)
-
10.4.3 India Computational Immunology Consumption (2017-2022)
-
10.4.4 South Korea Computational Immunology Consumption (2017-2022)
-
10.4.5 Pakistan Computational Immunology Consumption (2017-2022)
-
10.4.6 Bangladesh Computational Immunology Consumption (2017-2022)
-
10.4.7 Indonesia Computational Immunology Consumption (2017-2022)
-
10.4.8 Thailand Computational Immunology Consumption (2017-2022)
-
10.4.9 Singapore Computational Immunology Consumption (2017-2022)
-
10.4.10 Malaysia Computational Immunology Consumption (2017-2022)
-
10.4.11 Philippines Computational Immunology Consumption (2017-2022)
-
10.4.12 Vietnam Computational Immunology Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Computational Immunology Consumption (2017-2022)
-
10.5.2 Colombia Computational Immunology Consumption (2017-2022)
-
10.5.3 Chile Computational Immunology Consumption (2017-2022)
-
10.5.4 Argentina Computational Immunology Consumption (2017-2022)
-
10.5.5 Venezuela Computational Immunology Consumption (2017-2022)
-
10.5.6 Peru Computational Immunology Consumption (2017-2022)
-
10.5.7 Puerto Rico Computational Immunology Consumption (2017-2022)
-
10.5.8 Ecuador Computational Immunology Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Computational Immunology Consumption (2017-2022)
-
10.6.2 Kuwait Computational Immunology Consumption (2017-2022)
-
10.6.3 Oman Computational Immunology Consumption (2017-2022)
-
10.6.4 Qatar Computational Immunology Consumption (2017-2022)
-
10.6.5 Saudi Arabia Computational Immunology Consumption (2017-2022)
-
10.6.6 United Arab Emirates Computational Immunology Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Computational Immunology Consumption (2017-2022)
-
10.7.2 South Africa Computational Immunology Consumption (2017-2022)
-
10.7.3 Egypt Computational Immunology Consumption (2017-2022)
-
10.7.4 Algeria Computational Immunology Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Computational Immunology Consumption (2017-2022)
-
10.8.2 New Zealand Computational Immunology Consumption (2017-2022)
11 Global Computational Immunology Competitive Analysis
-
11.1 IMGT
-
11.1.1 IMGT Company Details
-
11.1.2 IMGT Computational Immunology Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 IMGT Computational Immunology Main Business and Markets Served
-
11.1.4 IMGT Computational Immunology Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Dassault Systemes
-
11.2.1 Dassault Systemes Company Details
-
11.2.2 Dassault Systemes Computational Immunology Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Dassault Systemes Computational Immunology Main Business and Markets Served
-
11.2.4 Dassault Systemes Computational Immunology Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Strand Life Sciences
-
11.3.1 Strand Life Sciences Company Details
-
11.3.2 Strand Life Sciences Computational Immunology Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Strand Life Sciences Computational Immunology Main Business and Markets Served
-
11.3.4 Strand Life Sciences Computational Immunology Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Nimbus Discovery
-
11.4.1 Nimbus Discovery Company Details
-
11.4.2 Nimbus Discovery Computational Immunology Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Nimbus Discovery Computational Immunology Main Business and Markets Served
-
11.4.4 Nimbus Discovery Computational Immunology Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Certara
-
11.5.1 Certara Company Details
-
11.5.2 Certara Computational Immunology Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Certara Computational Immunology Main Business and Markets Served
-
11.5.4 Certara Computational Immunology Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Novozymes Biopharma
-
11.6.1 Novozymes Biopharma Company Details
-
11.6.2 Novozymes Biopharma Computational Immunology Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Novozymes Biopharma Computational Immunology Main Business and Markets Served
-
11.6.4 Novozymes Biopharma Computational Immunology Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Simulation Plus
-
11.7.1 Simulation Plus Company Details
-
11.7.2 Simulation Plus Computational Immunology Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Simulation Plus Computational Immunology Main Business and Markets Served
-
11.7.4 Simulation Plus Computational Immunology Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Leadscope Inc
-
11.8.1 Leadscope Inc Company Details
-
11.8.2 Leadscope Inc Computational Immunology Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Leadscope Inc Computational Immunology Main Business and Markets Served
-
11.8.4 Leadscope Inc Computational Immunology Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 ioGenetics
-
11.9.1 ioGenetics Company Details
-
11.9.2 ioGenetics Computational Immunology Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 ioGenetics Computational Immunology Main Business and Markets Served
-
11.9.4 ioGenetics Computational Immunology Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 International Society of Vaccines
-
11.10.1 International Society of Vaccines Company Details
-
11.10.2 International Society of Vaccines Computational Immunology Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 International Society of Vaccines Computational Immunology Main Business and Markets Served
-
11.10.4 International Society of Vaccines Computational Immunology Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Schrodinger
-
11.11.1 Schrodinger Company Details
-
11.11.2 Schrodinger Computational Immunology Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Schrodinger Computational Immunology Main Business and Markets Served
-
11.11.4 Schrodinger Computational Immunology Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Compugen
-
11.12.1 Compugen Company Details
-
11.12.2 Compugen Computational Immunology Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Compugen Computational Immunology Main Business and Markets Served
-
11.12.4 Compugen Computational Immunology Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Genedata AG
-
11.13.1 Genedata AG Company Details
-
11.13.2 Genedata AG Computational Immunology Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Genedata AG Computational Immunology Main Business and Markets Served
-
11.13.4 Genedata AG Computational Immunology Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 Chemical Computing Group
-
11.14.1 Chemical Computing Group Company Details
-
11.14.2 Chemical Computing Group Computational Immunology Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 Chemical Computing Group Computational Immunology Main Business and Markets Served
-
11.14.4 Chemical Computing Group Computational Immunology Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 EpiVax
-
11.15.1 EpiVax Company Details
-
11.15.2 EpiVax Computational Immunology Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 EpiVax Computational Immunology Main Business and Markets Served
-
11.15.4 EpiVax Computational Immunology Product Portfolio
-
11.15.5 Recent Research and Development Strategies
-
11.16 Insilico Biotechnology AG
-
11.16.1 Insilico Biotechnology AG Company Details
-
11.16.2 Insilico Biotechnology AG Computational Immunology Sales, Price, Value and Gross Profit (2017-2022)
-
11.16.3 Insilico Biotechnology AG Computational Immunology Main Business and Markets Served
-
11.16.4 Insilico Biotechnology AG Computational Immunology Product Portfolio
-
11.16.5 Recent Research and Development Strategies
-
11.17 Rosa & Co
-
11.17.1 Rosa & Co Company Details
-
11.17.2 Rosa & Co Computational Immunology Sales, Price, Value and Gross Profit (2017-2022)
-
11.17.3 Rosa & Co Computational Immunology Main Business and Markets Served
-
11.17.4 Rosa & Co Computational Immunology Product Portfolio
-
11.17.5 Recent Research and Development Strategies
12 Global Computational Immunology Market Outlook by Types and Applications to 2028
-
12.1 Global Computational Immunology Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Cancer Diagnosis & Therapy Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Reverse Vaccinology Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Immune System Modeling Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Computational Immunology Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Allergy Prediction Databases Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Analysis Resource Database Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global International Immunogenetics System Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global The Ontology Of Immune Epitopes Consumption Forecast and Growth Rate (2022-2028)
-
12.2.5 Global Immune Epitope Database Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Computational Immunology Market Analysis and Outlook to 2028
-
13.1 Global Computational Immunology Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Computational Immunology Consumption Forecast (2022-2028)
-
13.2.2 Canada Computational Immunology Consumption Forecast (2022-2028)
-
13.2.3 Mexico Computational Immunology Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Computational Immunology Consumption Forecast (2022-2028)
-
13.3.2 UK Computational Immunology Consumption Forecast (2022-2028)
-
13.3.3 Spain Computational Immunology Consumption Forecast (2022-2028)
-
13.3.4 Belgium Computational Immunology Consumption Forecast (2022-2028)
-
13.3.5 France Computational Immunology Consumption Forecast (2022-2028)
-
13.3.6 Italy Computational Immunology Consumption Forecast (2022-2028)
-
13.3.7 Denmark Computational Immunology Consumption Forecast (2022-2028)
-
13.3.8 Finland Computational Immunology Consumption Forecast (2022-2028)
-
13.3.9 Norway Computational Immunology Consumption Forecast (2022-2028)
-
13.3.10 Sweden Computational Immunology Consumption Forecast (2022-2028)
-
13.3.11 Poland Computational Immunology Consumption Forecast (2022-2028)
-
13.3.12 Russia Computational Immunology Consumption Forecast (2022-2028)
-
13.3.13 Turkey Computational Immunology Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Computational Immunology Consumption Forecast (2022-2028)
-
13.4.2 Japan Computational Immunology Consumption Forecast (2022-2028)
-
13.4.3 India Computational Immunology Consumption Forecast (2022-2028)
-
13.4.4 South Korea Computational Immunology Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Computational Immunology Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Computational Immunology Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Computational Immunology Consumption Forecast (2022-2028)
-
13.4.8 Thailand Computational Immunology Consumption Forecast (2022-2028)
-
13.4.9 Singapore Computational Immunology Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Computational Immunology Consumption Forecast (2022-2028)
-
13.4.11 Philippines Computational Immunology Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Computational Immunology Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Computational Immunology Consumption Forecast (2022-2028)
-
13.5.2 Colombia Computational Immunology Consumption Forecast (2022-2028)
-
13.5.3 Chile Computational Immunology Consumption Forecast (2022-2028)
-
13.5.4 Argentina Computational Immunology Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Computational Immunology Consumption Forecast (2022-2028)
-
13.5.6 Peru Computational Immunology Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Computational Immunology Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Computational Immunology Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Computational Immunology Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Computational Immunology Consumption Forecast (2022-2028)
-
13.6.3 Oman Computational Immunology Consumption Forecast (2022-2028)
-
13.6.4 Qatar Computational Immunology Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Computational Immunology Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Computational Immunology Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Computational Immunology Consumption Forecast (2022-2028)
-
13.7.2 South Africa Computational Immunology Consumption Forecast (2022-2028)
-
13.7.3 Egypt Computational Immunology Consumption Forecast (2022-2028)
-
13.7.4 Algeria Computational Immunology Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Computational Immunology Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Computational Immunology Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Computational Immunology
-
Figure of Computational Immunology Picture
-
Table Global Computational Immunology Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Computational Immunology Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Cancer Diagnosis & Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Reverse Vaccinology Consumption and Growth Rate (2017-2022)
-
Figure Global Immune System Modeling Consumption and Growth Rate (2017-2022)
-
Figure Global Allergy Prediction Databases Consumption and Growth Rate (2017-2022)
-
Figure Global Analysis Resource Database Consumption and Growth Rate (2017-2022)
-
Figure Global International Immunogenetics System Consumption and Growth Rate (2017-2022)
-
Figure Global The Ontology Of Immune Epitopes Consumption and Growth Rate (2017-2022)
-
Figure Global Immune Epitope Database Consumption and Growth Rate (2017-2022)
-
Figure Global Computational Immunology Consumption by Country (2017-2022)
-
Table North America Computational Immunology Consumption by Country (2017-2022)
-
Figure United States Computational Immunology Consumption and Growth Rate (2017-2022)
-
Figure Canada Computational Immunology Consumption and Growth Rate (2017-2022)
-
Figure Mexico Computational Immunology Consumption and Growth Rate (2017-2022)
-
Table Europe Computational Immunology Consumption by Country (2017-2022)
-
Figure Germany Computational Immunology Consumption and Growth Rate (2017-2022)
-
Figure UK Computational Immunology Consumption and Growth Rate (2017-2022)
-
Figure Spain Computational Immunology Consumption and Growth Rate (2017-2022)
-
Figure Belgium Computational Immunology Consumption and Growth Rate (2017-2022)
-
Figure France Computational Immunology Consumption and Growth Rate (2017-2022)
-
Figure Italy Computational Immunology Consumption and Growth Rate (2017-2022)
-
Figure Denmark Computational Immunology Consumption and Growth Rate (2017-2022)
-
Figure Finland Computational Immunology Consumption and Growth Rate (2017-2022)
-
Figure Norway Computational Immunology Consumption and Growth Rate (2017-2022)
-
Figure Sweden Computational Immunology Consumption and Growth Rate (2017-2022)
-
Figure Poland Computational Immunology Consumption and Growth Rate (2017-2022)
-
Figure Russia Computational Immunology Consumption and Growth Rate (2017-2022)
-
Figure Turkey Computational Immunology Consumption and Growth Rate (2017-2022)
-
Table APAC Computational Immunology Consumption by Country (2017-2022)
-
Figure China Computational Immunology Consumption and Growth Rate (2017-2022)
-
Figure Japan Computational Immunology Consumption and Growth Rate (2017-2022)
-
Figure India Computational Immunology Consumption and Growth Rate (2017-2022)
-
Figure South Korea Computational Immunology Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Computational Immunology Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Computational Immunology Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Computational Immunology Consumption and Growth Rate (2017-2022)
-
Figure Thailand Computational Immunology Consumption and Growth Rate (2017-2022)
-
Figure Singapore Computational Immunology Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Computational Immunology Consumption and Growth Rate (2017-2022)
-
Figure Philippines Computational Immunology Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Computational Immunology Consumption and Growth Rate (2017-2022)
-
Table South America Computational Immunology Consumption by Country (2017-2022)
-
Figure Brazil Computational Immunology Consumption and Growth Rate (2017-2022)
-
Figure Colombia Computational Immunology Consumption and Growth Rate (2017-2022)
-
Figure Chile Computational Immunology Consumption and Growth Rate (2017-2022)
-
Figure Argentina Computational Immunology Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Computational Immunology Consumption and Growth Rate (2017-2022)
-
Figure Peru Computational Immunology Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Computational Immunology Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Computational Immunology Consumption and Growth Rate (2017-2022)
-
Table GCC Computational Immunology Consumption by Country (2017-2022)
-
Figure Bahrain Computational Immunology Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Computational Immunology Consumption and Growth Rate (2017-2022)
-
Figure Oman Computational Immunology Consumption and Growth Rate (2017-2022)
-
Figure Qatar Computational Immunology Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Computational Immunology Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Computational Immunology Consumption and Growth Rate (2017-2022)
-
Table Africa Computational Immunology Consumption by Country (2017-2022)
-
Figure Nigeria Computational Immunology Consumption and Growth Rate (2017-2022)
-
Figure South Africa Computational Immunology Consumption and Growth Rate (2017-2022)
-
Figure Egypt Computational Immunology Consumption and Growth Rate (2017-2022)
-
Figure Algeria Computational Immunology Consumption and Growth Rate (2017-2022)
-
Table Oceania Computational Immunology Consumption by Country (2017-2022)
-
Figure Australia Computational Immunology Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Computational Immunology Consumption and Growth Rate (2017-2022)
-
Table IMGT Company Details
-
Table IMGT Computational Immunology Sales, Price, Value and Gross Profit (2017-2022)
-
Table IMGT Computational Immunology Main Business and Markets Served
-
Table IMGT Computational Immunology Product Portfolio
-
Table Dassault Systemes Company Details
-
Table Dassault Systemes Computational Immunology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dassault Systemes Computational Immunology Main Business and Markets Served
-
Table Dassault Systemes Computational Immunology Product Portfolio
-
Table Strand Life Sciences Company Details
-
Table Strand Life Sciences Computational Immunology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Strand Life Sciences Computational Immunology Main Business and Markets Served
-
Table Strand Life Sciences Computational Immunology Product Portfolio
-
Table Nimbus Discovery Company Details
-
Table Nimbus Discovery Computational Immunology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Nimbus Discovery Computational Immunology Main Business and Markets Served
-
Table Nimbus Discovery Computational Immunology Product Portfolio
-
Table Certara Company Details
-
Table Certara Computational Immunology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Certara Computational Immunology Main Business and Markets Served
-
Table Certara Computational Immunology Product Portfolio
-
Table Novozymes Biopharma Company Details
-
Table Novozymes Biopharma Computational Immunology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novozymes Biopharma Computational Immunology Main Business and Markets Served
-
Table Novozymes Biopharma Computational Immunology Product Portfolio
-
Table Simulation Plus Company Details
-
Table Simulation Plus Computational Immunology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Simulation Plus Computational Immunology Main Business and Markets Served
-
Table Simulation Plus Computational Immunology Product Portfolio
-
Table Leadscope Inc Company Details
-
Table Leadscope Inc Computational Immunology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Leadscope Inc Computational Immunology Main Business and Markets Served
-
Table Leadscope Inc Computational Immunology Product Portfolio
-
Table ioGenetics Company Details
-
Table ioGenetics Computational Immunology Sales, Price, Value and Gross Profit (2017-2022)
-
Table ioGenetics Computational Immunology Main Business and Markets Served
-
Table ioGenetics Computational Immunology Product Portfolio
-
Table International Society of Vaccines Company Details
-
Table International Society of Vaccines Computational Immunology Sales, Price, Value and Gross Profit (2017-2022)
-
Table International Society of Vaccines Computational Immunology Main Business and Markets Served
-
Table International Society of Vaccines Computational Immunology Product Portfolio
-
Table Schrodinger Company Details
-
Table Schrodinger Computational Immunology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Schrodinger Computational Immunology Main Business and Markets Served
-
Table Schrodinger Computational Immunology Product Portfolio
-
Table Compugen Company Details
-
Table Compugen Computational Immunology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Compugen Computational Immunology Main Business and Markets Served
-
Table Compugen Computational Immunology Product Portfolio
-
Table Genedata AG Company Details
-
Table Genedata AG Computational Immunology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genedata AG Computational Immunology Main Business and Markets Served
-
Table Genedata AG Computational Immunology Product Portfolio
-
Table Chemical Computing Group Company Details
-
Table Chemical Computing Group Computational Immunology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Chemical Computing Group Computational Immunology Main Business and Markets Served
-
Table Chemical Computing Group Computational Immunology Product Portfolio
-
Table EpiVax Company Details
-
Table EpiVax Computational Immunology Sales, Price, Value and Gross Profit (2017-2022)
-
Table EpiVax Computational Immunology Main Business and Markets Served
-
Table EpiVax Computational Immunology Product Portfolio
-
Table Insilico Biotechnology AG Company Details
-
Table Insilico Biotechnology AG Computational Immunology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Insilico Biotechnology AG Computational Immunology Main Business and Markets Served
-
Table Insilico Biotechnology AG Computational Immunology Product Portfolio
-
Table Rosa & Co Company Details
-
Table Rosa & Co Computational Immunology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Rosa & Co Computational Immunology Main Business and Markets Served
-
Table Rosa & Co Computational Immunology Product Portfolio
-
Figure Global Cancer Diagnosis & Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Reverse Vaccinology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immune System Modeling Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Allergy Prediction Databases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Analysis Resource Database Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global International Immunogenetics System Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global The Ontology Of Immune Epitopes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immune Epitope Database Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Computational Immunology Consumption Forecast by Country (2022-2028)
-
Table North America Computational Immunology Consumption Forecast by Country (2022-2028)
-
Figure United States Computational Immunology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Computational Immunology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Computational Immunology Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Computational Immunology Consumption Forecast by Country (2022-2028)
-
Figure Germany Computational Immunology Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Computational Immunology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Computational Immunology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Computational Immunology Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Computational Immunology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Computational Immunology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Computational Immunology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Computational Immunology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Computational Immunology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Computational Immunology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Computational Immunology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Computational Immunology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Computational Immunology Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Computational Immunology Consumption Forecast by Country (2022-2028)
-
Figure China Computational Immunology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Computational Immunology Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Computational Immunology Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Computational Immunology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Computational Immunology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Computational Immunology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Computational Immunology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Computational Immunology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Computational Immunology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Computational Immunology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Computational Immunology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Computational Immunology Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Computational Immunology Consumption Forecast by Country (2022-2028)
-
Figure Brazil Computational Immunology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Computational Immunology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Computational Immunology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Computational Immunology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Computational Immunology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Computational Immunology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Computational Immunology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Computational Immunology Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Computational Immunology Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Computational Immunology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Computational Immunology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Computational Immunology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Computational Immunology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Computational Immunology Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Computational Immunology Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Computational Immunology Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Computational Immunology Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Computational Immunology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Computational Immunology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Computational Immunology Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Computational Immunology Consumption Forecast by Country (2022-2028)
-
Figure Australia Computational Immunology Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Computational Immunology Consumption Forecast and Growth Rate (2022-2028)
-
